| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.1M | +22.8% |
| R&D Expense | $66.9M | +78.3% |
| SG&A Expense | $13.0M | +23.6% |
| Operating Income | -$70.8M | -74.3% |
| Income Tax | $0 | — |
| Net Income | -$76.3M | -94.9% |
| EPS (Basic) | -$2.10 | -7.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $53.7M | -9.7% |
| Current Assets | $58.0M | -7.6% |
| Total Assets | $62.2M | -8.3% |
| Current Liabilities | $22.1M | +23.2% |
| Total Liabilities | $51.5M | +101.4% |
| Stockholders' Equity | $10.7M | -74.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$65.1M | -102.3% |
| Capital Expenditures | $11K | — |
| Investing Cash Flow | -$11K | — |
| Financing Cash Flow | $59.4M | +91.1% |
| Free Cash Flow | -$65.1M | -102.3% |